---
$id: https://graph.org.ai/products/commodity/51162727
$type: Product
source: UNSPSC
code: "51162727"
title: "Guaifenesin"
class: "51162700"
classTitle: "Decongestants, expectorants, and mucolytics"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Guaifenesin

**UNSPSC Code**: 51162727
**Class**: [Decongestants, expectorants, and mucolytics](Decongestants, expectorants, and mucolytics.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an expectorant with the molecular formula C10H14O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 495W7451VQ, chemically known as 1,2,3-propanetriol, ether with 2-methoxyphenol but more generally known as guaifenesin, which bears US NIH Compound Identifier 3516. European Medicines Agency schedules Guaifenesin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07973MIG. The term GUAIFENESIN is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 25 , No. 10 1971, List 11). World Health Organization schedules guaifenesin in its Anatomical Therapeutic Chemical (ATC) Classification. GUAIFENESIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule guaifenesin under HS 29094990 and SITC 51617. As of Q4 2014, GUAIFENESIN remains US FDA's Preferred Term for this commodity. Guaifenesin bears US NLM identifiers UMLS ID C0018305 and NCI Concept Code C29081. SMILES: COC1=CC=CC=C1OCC(CO)O.

